Resource Centers
Slideshow
- Enrollment Halts in Randomized Trial of CPR for Out-of-Hospital Arrest
- Limiting Working Hours May Compromise Surgeons' Education and Patient Care
- Most Medicaid Programs Fail to Provide Unrestricted Access to Smoking Cessation Therapies
- Prehospital Triage "Immediately Successful" in Boosting Rates of Thrombolytic Therapy for Stroke
- Alert Dutch Pull Pfizer Vaccine Batch After Infants Die
Medscape Journals
Specialty Spotlight
-
Exploring Genetic Susceptibility to Autism: An Expert Interview With Hakon Hakonarson, MD, PhD
-
Can the Nurse Practitioner Write a Prescription For Someone Who Is Not a Patient?
-
Chronic Obstructive Pulmonary Disease: Part 2: Prevention and Long-term Treatment
-
Testing for H1N1 Influenza in the Emergency Department
-
Physicians Are Talking About: A Death Foretold
Medscape Community Resources
- A Successful Campaign Against Antibiotic Overuse
- Will There Ever Be a Big Brown Ribbon Outside the White House?
- Exploring Genetic Susceptibility to Autism: An Expert Interview With Hakon Hakonarson, MD, PhD
- Can the Nurse Practitioner Write a Prescription For Someone Who Is Not a Patient?
- Testing for H1N1 Influenza in the Emergency Department
POLL
The Obama administration recently told federal prosecutors not to pursue patients who use medical marijuana in states where it is legal, unless they are using it for illegal purposes. Do you approve or disapprove of the policy change?
- A Treatment Option for Atrial Fibrillation
- A single medication with 4 indications
- A treatment option for ACS and DVT/PE
- ABILIFY® (aripiprazole)
- ACUVUE® Brand Contact Lenses
- ADHD treatment: Efficacy, insights, and dosing
- ALIMTA® (pemetrexed for injection)
- Argatroban
- Atrial Fibrillation Condition Site
- COSAMIN®DS
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- Clinical Management Center
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- ENABLEX® (darifenacin) Extended-Release Tablets 7.5 mg or 15 mg
- Epilepsy360: Connections in Care
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEMZAR® (gemcitabine HCI)
- GEODON® (ziprasidone HCI)
- Genomic Advances in Cardiovascular Care
- Heartmate II® Left Ventricular Assist System
- IL-6 and Rheumatoid Arthritis
- ISENTRESS® (raltegravir) Tablets
- Kidney Transplantation
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NUCYNTA™ (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- Navigenics® Genetic Risk Assessment Services
- Neuroendocrine tumors: Increasing in incidence and easy to overlook
- Neutrogena® Pure & Free™ Baby Sunblock Lotion
- OPTIMAL Forum™
- Onglyza™ (saxagliptin) InfoSite
- PEGASYS (peginterferon alfa-2a) for injection
- PREMARIN® (conjugated estrogens tablets, USP)
- PRISTIQ® (desvenlafaxine)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- QuickVue® Influenza A+B Test
- REBIF® (interferon beta-1a)
- RITUXAN® (Rituximab)
- Reclast® (zoledronic acid) injection
- Research VEGF: Emerging Research Around Targeting VEGF
- Risk of Osteoporosis
- Survivorship and Early Breast Cancer Information
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- TOVIAZ® (fesoterodine fumarate)
- Talecris Hypermunes™
- Targeted Biologic Therapy in Breast Cancer
- Targeting CD20: Scientific Insights and Implications for Therapy
- The HER signaling network and cancer
- The Pain Institute
- The Science of Facial Aging
- Treatment of Pulmonary Arterial Hypertension
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
- XYZAL® (levocetirizine dihydrochloride)
